Wolverine Trading, LLC Amicus Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $247,345 - $313,131	25,900 New	25,900 $276,000
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $20,937 - $30,492	-2,100 Reduced 12.73%	14,400 $204,000
Q3 2023 Nov 15, 2023	BUY	$11.78 - $13.86 $76,570 - $90,090	6,500 Added 65.0%	16,500 $200,000
Q2 2023 Aug 23, 2023	BUY	$10.72 - $13.3 $107,200 - $133,000	10,000 New	10,000 $125,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $150,246 - $195,075	15,300 New	15,300 $157,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $154,698 - $209,568	-17,700 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$8.71 - $10.72 $263,913 - $324,816	-30,300 Reduced 63.13%	17,700 $176,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $292,560 - $758,748	31,800 Added 196.3%	48,000 $451,000
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $86,208 - $159,296	-6,400 Reduced 28.32%	16,200 $372,000
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $210,107 - $259,007	-16,300 Reduced 41.9%	22,600 $318,000
Q2 2020 Aug 13, 2020	SELL	$8.86 - $15.69 $3,544 - $6,276	-400 Reduced 1.02%	38,900 $605,000
Q1 2020 May 11, 2020	BUY	$6.63 - $11.16 $11,271 - $18,972	1,700 Added 4.52%	39,300 $382,000
Q4 2019 Feb 12, 2020	SELL	$7.48 - $10.75 $30,668 - $44,075	-4,100 Reduced 9.83%	37,600 $358,000
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $74,586 - $123,225	-9,300 Reduced 18.24%	41,700 $336,000
Q2 2019 Aug 20, 2019	BUY	$10.96 - $14.4 $320,032 - $420,480	29,200 Added 133.94%	51,000 $636,000
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $20,080 - $27,840	-2,000 Reduced 8.4%	21,800 $296,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $537,158 - $861,504	-64,100 Reduced 72.92%	23,800 $220,000
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $483,720 - $689,718	-41,700 Reduced 32.18%	87,900 $1.06 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $872,384 - $1.09 Million	63,400 Added 95.77%	129,600 $1.95 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $68,805 - $89,319	-5,500 Reduced 7.67%	66,200 $953,000
Q3 2017 Nov 15, 2017	BUY	$11.74 - $15.78 $841,758 - $1.13 Million	71,700	71,700 $1.08 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$283 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$276 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$236 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$228 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account